CPT® Code 83906

Deleted

1. Indications

The procedure associated with CPT® Code 83906 is indicated for the identification of specific genetic mutations that may be relevant to various diseases. This testing is particularly useful in the following scenarios:

• Genetic Testing for Hereditary Conditions This test is performed to identify mutations that may be inherited and could lead to hereditary diseases.
• Oncology It is utilized in cancer diagnostics to detect mutations that may influence treatment decisions and prognostic evaluations.
• Pharmacogenomics The procedure can assist in determining how genetic variations affect an individual's response to certain medications.

2. Procedure

The procedure for CPT® Code 83906 involves several key steps to ensure accurate mutation identification through allele-specific translation. Each step is critical for the successful execution of the test:

• Sample Collection A biological sample, typically blood or tissue, is collected from the patient. This sample serves as the source of DNA for analysis.
• DNA Extraction The DNA is extracted from the collected sample using standardized laboratory techniques to ensure purity and integrity for testing.
• Allele-Specific Translation The extracted DNA is subjected to allele-specific translation, where specific primers are used to amplify the target segment of DNA that contains the mutation of interest. This step is crucial for isolating the segment that will be analyzed.
• Mutation Identification The amplified DNA is then analyzed to identify the presence of specific mutations. This may involve various molecular techniques, such as sequencing or hybridization, to confirm the presence of the allele.
• Result Interpretation Finally, the results are interpreted by qualified laboratory personnel, and a report is generated detailing the findings, which can then be used by healthcare providers for further clinical decision-making.

3. Post-Procedure

After the completion of the procedure associated with CPT® Code 83906, the patient may not require any specific post-procedure care, as the test is non-invasive and typically does not involve any physical intervention. However, it is essential for healthcare providers to discuss the results with the patient once they are available. This discussion may include the implications of the identified mutations, potential health risks, and any necessary follow-up actions or treatments based on the findings. Additionally, patients may be advised to maintain regular follow-up appointments to monitor any health changes related to the identified genetic mutations.